---
title: "SENSSUN released its performance for the first three quarters, with a net profit attributable to the parent company of 90.5368 million yuan, a decrease of 27.71%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263026264.md"
description: "SENSSUN released its third-quarter report for 2025, with operating revenue for the first three quarters amounting to 4.47 billion yuan, a year-on-year increase of 1.54%. The net profit attributable to the parent company was 90.5368 million yuan, a year-on-year decrease of 27.71%; the net profit excluding non-recurring gains and losses was 86.8757 million yuan, a year-on-year decrease of 27.66%. The basic earnings per share were 0.69 yuan"
datetime: "2025-10-28T08:01:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263026264.md)
  - [en](https://longbridge.com/en/news/263026264.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263026264.md)
generator: "portal-rs"
---

# SENSSUN released its performance for the first three quarters, with a net profit attributable to the parent company of 90.5368 million yuan, a decrease of 27.71%

According to the Zhitong Finance APP, SENSSUN (002870.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 4.47 billion yuan, a year-on-year increase of 1.54%. The net profit attributable to shareholders of the listed company was 90.5368 million yuan, a year-on-year decrease of 27.71%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 86.8757 million yuan, a year-on-year decrease of 27.66%. The basic earnings per share were 0.69 yuan

### Related Stocks

- [002870.CN](https://longbridge.com/en/quote/002870.CN.md)

## Related News & Research

- [There's A Lot To Like About Zur Shamir Holdings' (TLV:ZUR) Upcoming ₪0.0916074 Dividend](https://longbridge.com/en/news/297594921.md)
- [Baidu shifts Hong Kong listing to dual-primary from secondary listing](https://longbridge.com/en/news/297571992.md)
- [Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) Short Interest Update](https://longbridge.com/en/news/297430072.md)
- [Xinhua Pharma unit Xincat’s azithromycin tablets pass China generic consistency evaluation](https://longbridge.com/en/news/297485179.md)
- [Bouygues: Disclosure of trading in own shares](https://longbridge.com/en/news/297541597.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**